Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man.
D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000139:chemically induced*; D003981:Diazoxide / Q000009:adverse effects / Q000494:pharmacology*; D004357:Drug Synergism; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced*; D007008:Hypokalemia / Q000139:chemically induced; D007328:Insulin / Q000097:blood; D007329:Insulin Antagonists; D011188:Potassium / Q000097:blood; D014237:Trichlormethiazide / Q000009:adverse effects / Q000494:pharmacology*
D001786:Blood Glucose; D007328:Insulin; D007329:Insulin Antagonists; D003981:Diazoxide; D014237:Trichlormethiazide; D011188:Potassium